drugset / Trial / NCT02305017

Effect of Paracetamol on Opicapone Pharmacokinetics in Healthy Volunteers

NCT02305017

Phase 1 Completed 28 enrolled Bial - Portela C S.A.
RandomizedCrossoverOpen-labelTreatment

Summary

Single-centre, open-label, randomised, two-way cross-over study consisting of 2 periods separated by a washout period of 14 days or more.

Timeline

Start
2014-03
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 1 g
Subject Opicapone Small molecule 50 mg

Indications